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A B S T R A C T
The V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 exterior envelope glycoprotein (Env)
becomes exposed after CD4 binding and contacts the coreceptor to mediate viral entry. Prior to CD4 engage-
ment, a hydrophobic patch located at the tip of the V3 loop stabilizes the non-covalent association of gp120 with
the Env trimer of HIV-1 subtype B strains. Here, we show that this conserved hydrophobic patch (amino acid
residues 307, 309 and 317) contributes to gp120-trimer association in HIV-1 subtype C, HIV-2 and SIV. Changes
that reduced the hydrophobicity of these V3 residues resulted in increased gp120 shedding and decreased Env-
mediated cell-cell fusion and virus entry in the different primate immunodeficiency viruses tested. Thus, the
hydrophobic patch is an evolutionarily conserved element in the tip of the gp120 V3 loop that plays an essential
role in maintaining the stability of the pre-triggered Env trimer in diverse primate immunodeficiency viruses.
1. Introduction
The third variable (V3) loop of the gp120 envelope glycoprotein
(Env) on the surface of human immunodeficiency virus type 1 (HIV-1)
becomes exposed after the virus binds CD4, the initial receptor; the V3
loop plays an important role in contacting the coreceptor CCR5 or
CXCR4 to mediate viral entry (Cashin et al., 2013; Foda et al., 2001;
Hartley et al., 2005; Hongjaisee et al., 2017; Huang et al., 2005; Jiang
et al., 2010; Moore and Nara, 1991). The sequence of the V3 loop de-
termines HIV-1 tropism, dictating the choice of the coreceptor, CCR5 or
CXCR4 (Cardozo et al., 2007; Cashin et al., 2013; Conley et al., 1994;
Kumar and Raghava, 2013; Scheib et al., 2006; Svicher et al., 2011).
The V3 loop is also immunogenic, and neutralizing antibodies against
V3 often dominate immune responses following Env immunization
(Jacob et al., 2015; Julien et al., 2013b; Li et al., 2015; Sirois et al.,
2007; Stanfield and Wilson, 2005; Totrov et al., 2010; Watkins et al.,
2011; Zolla-Pazner, 2005). In addition to its role in HIV-1 entry and
immunogenicity, the V3 loop contributes to the non-covalent associa-
tion of gp120 with the Env trimer, during the assembly of the viral Env
spike (Xiang et al., 2010). In primary HIV-1 strains, the length of the V3
loop is extremely constrained by this assembly requirement; even the
insertion of a single glycine residue in the V3 stem leads to destabili-
zation of the Env trimer and shedding of gp120 (Xiang et al., 2010). A
hydrophobic patch located in the V3 tip region has been shown to be
critical for envelope trimer stability in HIV-1 subtype B strains (Xiang
et al., 2010). A single-residue change to a hydrophilic or even to a
neutral residue in this hydrophobic patch destabilizes the Env trimer
and results in an increase of gp120 shedding, a decrease of Env-medi-
ated membrane fusion and a reduction in virus infectivity. In available
structural models of the HIV-1 Env trimer (Julien et al., 2013a; Lee
et al., 2016; Lyumkis et al., 2013; Pancera et al., 2014), the V3 loop is
located at the apex of the trimer along with the gp120 V1 and V2
variable regions. This apical location potentially allows the V3 loop to
participate in interprotomer contacts that contribute to Env trimer
stability. For example, substitution of hydrophobic residues near the V3
hydrophobic patch raised the melting temperature of soluble gp140
SOSIP.664 Env trimers (de Taeye et al., 2018, 2015).
It is not known whether the V3 contribution to Env trimer stability
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is specific for HIV-1 subtype B strains or also applies to other HIV-1
subtypes or evolutionarily related primate lentiviruses (Hirsch et al.,
1995; Sharp and Hahn, 2011). Based on sequence alignment of the V3
region, the hydrophobic patch appears to be well conserved in HIV-1,
HIV-2 and the simian immunodeficiency viruses (SIVs), implying an
important function. However, given the differences between HIV-1 and
HIV-2/SIV with respect to the length and composition of the V1/V2
region (Bohl et al., 2013), the structural organization of the Env trimer
apex of these virus lineages may differ. Therefore, in this study, we
examined the role of the V3 loop hydrophobic patch and V3 loop length
in both HIV-1 and HIV-2 species, as well as in nonhuman primate
lentiviruses, SIVs. Our results support the hypothesis that the V3 loop
plays an important role in the stability of the unliganded HIV-1, HIV-2
and SIV Env trimers in addition to its role in contacting the coreceptor
for viral entry in the CD4-bound state of Env.
2. Results
2.1. A single glycine residue insertion in the gp120 V3 loop destabilizes Env
trimers from Clade C HIV-1
Although the length of the gp120 V3 loop is relatively conserved at
about 35 amino acids in the primate lentiviruses, there is some varia-
tion among viral species and strains (Fig. 1A). Surprisingly, in some
HIV-1 strains, a single glycine residue insertion in the V3 loop can be
lethal to the virus, a phenomenon that was first observed in primary
HIV-1 subtype B viruses (Xiang et al., 2010). The Glycine (G) insertions
were positioned between residues 303 and 304 or between residues 322
and 323; these insertions involve the variable stem region of V3 and
avoid known functional regions in the loop (e.g., coreceptor-binding
elements) (Fig. 1A and B). To evaluate whether this phenomenon is
specific to subtype B strains or also applies to other HIV-1 subtypes or
other primate lentiviruses, we investigated additional viruses, including
HIV-1 subtype C, HIV-2 and SIV. HIV-1 subtype C is the dominant clade
worldwide (Cashin et al., 2013; Jiang et al., 2010). To represent HIV-1
subtype C, two Zambian isolates, 1084i and ZM249M_B10 (ZM249),
were studied. Radiolabeled Envs from lysates and supernatants of ex-
pressing cells were assessed, allowing an evaluation of the efficiency of
Env precursor processing and gp120 association with the trimer. When
a glycine residue was inserted into the V3 loop at the 303 or 322 po-
sitions, an increase in gp120 shedding was observed (Fig. 2A, D). We
assessed the ability of the glycine-insertion mutants to mediate the
fusion of Env-expressing cells with CD4+CCR5+ cells, and to comple-
ment the entry of an env-defective reporter virus into TZM-bl cells. The
insertion of a glycine residue in the V3 loop significantly decreased Env-
mediated cell-cell fusion and resulted in a total loss of viral infectivity
(Fig. 2B, C, E, F). These data suggest that in Clade C HIV-1, as was
previously observed in HIV-1 subtype B strains, the V3 loop contributes
to the non-covalent association of gp120 with the pre-triggered Env
trimer.
2.2. Role of the V3 loop hydrophobic patch in HIV-1 subtype C
Three hydrophobic residues at positions 307, 309 and 317 con-
stitute a hydrophobic surface patch in available structures of the gp120
V3 loop (Xiang et al., 2010) (Fig. 1, B and C). Based on sequence
alignment, this patch appears to be conserved in all primate lenti-
viruses; although some variability is tolerated, residues 307, 309 and
317 are consistently hydrophobic (Fig. 1A). We investigated the effect
of specific changes in the hydrophobic patch in HIV-1 subtype C, using
the two Zambian strains ZM249 and 1084i. Three different substitu-
tions were made in each residue (307, 309 and 317) of the hydrophobic
patch: a relatively neutral alanine (A) residue, a hydrophilic glutamic
acid (E) residue or another hydrophobic residue, leucine (L). The results
for ZM249 and 1084i are shown in Figs. 3 and 4, respectively. It is
evident that one hydrophilic (to E) or neutral amino acid (to A)
Fig. 1. The gp120 V3 hydrophobic patch. (A). Alignment of the V3 loop sequences of primate immunodeficiency viruses. The amino acid residues are numbered
according to standard HIV-1 HXBc2 numbering, which is included as a reference (Korber et al., 1998). The hydrophobic patch residues that were altered in the study
are shown in yellow, and the locations of glycine insertions are indicated by an arrow. (B). Ribbon structure of the V3 loop in the sgp140 SOSIP.664 Env trimer (PDB:
4ZMJ). HP, hydrophobic patch indicated by the red circle. (C). The surface of the V3 loop in (B), showing the hydrophobic patch in the red circle. gray, hydrophobic,
blue, hydrophilic.
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substitution in any of the three residues of the V3 hydrophobic patch of
the ZM249 Env resulted in Env trimer destabilization and increased
shedding of gp120 (Fig. 3A, D, G). Substitution of the hydrophobic
leucine (L) residue resulted in less dramatic increases in gp120 shed-
ding. Decreases in gp120 association with the Env trimer also resulted
from the alanine and glutamic acid substitutions in residues 307, 309
and 317 of the 1084i Env, although the magnitude of these decreases
was less than that seen in the ZM249 Env. Similar to the results with the
ZM249 Env, the leucine substitution resulted in a phenotype that was
closer to that of the wild-type Env (Fig. 4A, D, G). These results support
a model in which the hydrophobicity of the V3 patch contributes to its
function in maintaining the stability of the Env trimer.
Consistent with the decrease in stability of the Env trimer, the ala-
nine and glutamic acid substitution mutants of ZM249 Env, and to a
lesser extent of the 1084i Env, exhibited a decrease in cell-cell fusion
(Fig. 3B, E, H and Fig. 4B, E, H). The leucine substitution mutants were
generally more capable of mediating cell-cell fusion than the alanine
and glutamic acid substitution mutants.
Complementation of virus entry was severely compromised by ala-
nine and glutamic acid substitutions in all three residues of the hy-
drophobic V3 patch (Fig. 3C, F, I and Fig. 4C, F, I). As has been seen for
other HIV-1 Env mutants with altered subunit association (Finzi et al.,
2010), virus infectivity was compromised to a greater degree than
syncytium-forming ability. The leucine substitution mutants retained
varying degrees of infectivity. The F317L mutant of ZM249 exhibited
wild-type levels of infectivity. The M307L mutant of the 1084i Env
supported virus entry significantly better than the wild-type 1084i Env;
apparently the methionine residue at 307, which is less common among
HIV-1 strains, is not as optimal for virus infectivity as the leucine re-
sidue. Changes in viral infection and cell-cell fusion also do not appear
Fig. 2. Characterization of V3 glycine-insertion mutants of HIV-1 subtype C strains (1084i and ZM249). (A, D). SDS-PAGE analysis of immunoprecipitated cell
lysates and supernatant fractions from cells expressing WT or mutant envelope proteins. The gp160 and gp120 bands are indicated. The association index provides an
indication of the non-covalent association of gp120 with the Env trimer, relative to that of the wild-type Env, and was calculated as previously reported (Finzi et al.,
2010). YU2 is a subtype B HIV-1 strain used as a positive control. (B, E) Cell-cell fusion assay. (C, F) Viral entry assay. HXBc2 is an X4 tropic subtype B HIV-1 virus
that was used as a negative control for viral entry. All the values of the mutants were normalized as percentages of those obtained with their respective wild-type
(WT) Env, as described in the Materials and Methods. The results shown are representative of three separate experiments performed in quadruplicate. Significance
was determined by the student's T-test [* ** *p < 0.001, * ** **p < 0.0001]. Un, untransfected negative-control cells.
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to be due to reduced CD4 binding, as alanine substitution mutants in
ZM249 exhibited no differences in affinity to CD4-Ig (Table 1). To-
gether, the ZM249 and 1084i Env mutant phenotypes support a role for
the hydrophobic V3 patch in the stability and function of Envs from
Clade C HIV-1 strains.
2.3. Role of the V3 loop hydrophobic patch in HIV-2
Human immunodeficiency virus type 2 (HIV-2) evolved from
SIVsmm species and thus represents a separate lineage from the HIV-
1M group, which is derived from SIVcpz viruses. Despite this, the hy-
drophobic patch is also well preserved in the gp120 V3 loops of HIV-2
species, based upon Env sequence alignment (Fig. 1A). To assess the
role of the hydrophobic patch in HIV-2, we chose a typical HIV-2 strain,
HIV-2 ST, to test. Alanine residues were substituted for the hydrophobic
patch residues at positions 307, 309 and 317. All three substitutions
caused a significant increase in gp120 shedding (Fig. 5A). This decrease
in Env stability also correlated with a decrease in cell-cell fusion cap-
ability. All three alanine substitutions significantly reduced Env-medi-
ated cell-cell fusion to background levels (Fig. 5B). Additionally, a
glycine insertion in the HIV-2 ST V3 loop (303Gi) also resulted in an
increase of gp120 shedding and a reduction in cell-cell fusion. The
I307A change did not affect the ability of Env to bind CD4-Ig, but the
alanine substitutions at positions 309 and 317 were associated with a
modest decrease in CD4-Ig binding (Fig. 5C). Overall, these data suggest
that the structural role and biological function of the V3 hydrophobic
patch is conserved in HIV-2 species.
2.4. Role of the V3 loop hydrophobic patch in nonhuman primate
lentiviruses
Nonhuman primate viruses are the sources of HIV-1 and HIV-2
(26–30). Sequence comparisons suggest that the V3 hydrophobic patch
is conserved in nonhuman lentiviruses (Fig. 1A). To determine whether
the structural and functional roles of the V3 loop hydrophobic patch are
conserved in non-human primate lentiviruses, we tested two typical SIV
strains. We introduced a glycine insertion and alanine substitutions into
the hydrophobic patch in the SIVmac239 envelope, and carried out the
Env functional assays described above. Interestingly, in SIVmac239, the
I309A change resulted in less shedding than the glycine insertion at
position 303 or the V307A and the F317A changes (Fig. 6A), as re-
flected in a much higher association index. This trend correlated well
with the cell-cell fusion and virus entry functions of these Envs, as fu-
sion of I309A was not significantly different from that of the wild-type
SIVmac239 Env (Fig. 6B); there was a detectable level of entry for the
I309A viruses, although still significantly reduced, whereas the other
Env mutants did not facilitate entry above the background level
(Fig. 6C). The SIVmac239 Env appears to be more tolerant of an alanine
residue at position 309 than at positions 307 and 317, and is better able
to tolerate the alteration of residue 309 than the other primate lenti-
viruses studied in this work.
The binding of the SIVmac239 Env mutants to CD4-Ig was not sig-
nificantly different from that of the WT Env (Fig. 6D); these results
indicate that the introduced changes did not result in a major con-
formational change in the gp120 structure that affected binding to CD4.
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Fig. 3. Characterization of hydrophobic-patch mutants of HIV-1 subtype C strain ZM249. (A, D, G). Immunoprecipitated cell lysates (CL) and supernatants
(Sup) of WT HIV-1 ZM249 Env and Env mutants with alanine (A), glutamic acid (E) and leucine (L) substitutions at three hydrophobic V3 loop positions (307, 309
and 317). The association index value was calculated as previously reported (Finzi et al., 2010). (B, E,H). Cell-cell fusion assays. (C, F,I). Viral entry assays. Un,
untransfected cells. Significance was determined by the student's T-test [* **p < 0.001, * ** *p < 0.0001]; n.s., not significant.
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We also altered the Env from another SIV strain, SIVagmTan1, in-
serting a glycine residue between residues 303 and 304, and sub-
stituting alanine residues for each of the residues associated with the
hydrophobic patch. The phenotypes of the insertion mutant 303Gi and
the three hydrophobic patch mutants (V307A, I309A and F317A) were
consistent with those observed in the other viruses studied above. The
introduced changes in the V3 loop resulted in decreased Env stability,
indicated by increased gp120 shedding, and a corresponding decrease
in the level of cell-cell fusion initiated by these mutant Envs (Fig. 6E, F).
We note that the signal: background ratio for cell-cell fusion initiated by
the SIVagmTan1 envelope was lower than that seen for the other Envs
described above. This may be a result of the TZM-bl target cells ex-
pressing human, not African green monkey, CD4 and CCR5.
3. Discussion
The gp120 V3 loop of primate immunodeficiency virus Envs is ty-
pically 35 amino acid residues in length and can be divided into the
base, stem and tip (4, 21). The amino acid sequences of the V3 base and
tip are more conserved than that of the stem. Mutagenesis studies have
implicated the V3 base and tip in contacting the CCR5 or CXCR4 cor-
eceptors: the V3 base contributes to the interaction with the sulfated N-
terminus of the coreceptor, whereas the V3 tip interacts with extra-
cellular loop 2 (ECL2) of the coreceptor (Abayev et al., 2015; Arimont
et al., 2017; Huang et al., 2007; Kufareva, 2016). Although the amino
acid sequences of the V3 stem are less conserved, our previous study
demonstrated that insertions of one or two glycine residues in the V3
stem severely compromised the function of Env from Clade B HIV-1
(Xiang et al., 2010). Part of this functional attenuation arises from
decreased coreceptor binding, presumably as a result of disruption of
the two-point contact of the V3 base and tip with the coreceptor. The
V3 loop length also appears to have been constrained by the require-
ment for gp120 to associate non-covalently with the assembled Env
trimer. Insertion of glycine residues in the V3 stem of Envs from Clade B
HIV-1 resulted in shedding of gp120 from the Env trimer, suggesting
that the V3 loop might contribute to the non-covalent association of
gp120 with the pre-triggered Env trimer (Xiang et al., 2010). Further
investigation revealed the importance of the hydrophobic patch in the
V3 tip in maintaining the stability of the assembled Env trimer (Xiang
et al., 2010). The association of gp120 with the Env trimer correlated
with the cell-cell fusion activity of panels of Env mutants derived from a
given primate immunodeficiency virus.
The results of our study indicate the general importance of the
gp120 V3 loop hydrophobic patch in the subunit association of primate
immunodeficiency virus Env trimers. Our observation that the stem
insertion mutants and hydrophobic patch mutants exhibit similar phe-
notypes with respect to gp120 shedding implies that precise spatial
interactions of the hydrophobic patch are required for Env trimer sta-
bility. On the available high-resolution structures of HIV-1 Env trimers
(Julien et al., 2013a; Lee et al., 2016; Lyumkis et al., 2013; Pancera
et al., 2014), the gp120 V1, V2 and V3 elements are located at the
trimer apex (Fig. 7A). In these structures, the V3 hydrophobic patch
Fig. 4. Characterization of hydrophobic-patch mutants of HIV-1 subtype C strain 1084i. (A, D,G). Immunoprecipitated cell lysates (CL) and supernatants (Sup)
of WT HIV-1 1084i Env and Env mutants with alanine (A), glutamic acid (E) and leucine (L) substitutions at three hydrophobic V3 loop positions (307, 309 and 317).
The association index value was calculated as previously reported (Finzi et al., 2010). YU2 is an Env from a subtype B HIV-1 strain used as a positive control. (B, E,H).
Cell-cell fusion assays. (C, F,I). Viral entry assays. Un, untransfected cells. Significance was determined by the student's T-test [* p < 0.05, * *p < 0.01,
* ** *p < 0.0001]; n.s., not significant.
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forms a hydrophobic core by a key-in-hole interaction with the V2 re-
gion (F159, M161, and V172) of the same gp120 subunit (Fig. 7B and
C). Alteration of the V3 and V2 hydrophobic interactions might
destabilize structures near the Env trimer apex that contribute to
maintenance of the pre-triggered conformation of the assembled trimer.
The structural models suggest that the V2 turn (residues 164–168)
immediately adjacent to the V3-V2 hydrophobic core is involved in
interprotomer interactions in the Env trimer. An indirect disruption of
these V2-mediated interprotomer interactions by alteration of the V3
hydrophobic patch might explain an “opening” of the trimer apex; such
HIV-1 mutants would be expected to maintain trimer integrity and re-
plication competence but exhibit increased neutralization sensitivity
(Herschhorn et al., 2016). The observed shedding of gp120 resulting
from the introduced V3 changes is more difficult to explain, as the
gp120 subunits exhibit numerous interactions with gp41 in current Env
trimer models (Julien et al., 2013a; Lee et al., 2016; Lyumkis et al.,
2013; Pancera et al., 2014). That the gp120 shedding phenotypes of the
V3 mutants result from indirect V2-mediated effects seems unlikely
when the direct alteration of V2 residues 164–168 did not yield gp120
shedding phenotypes; in fact, most of these V2 mutants exhibited
Table 1
Phenotypes of primate immunodeficiency virus mutants.
Env and
mutation
Association
index a
Cell-cell
fusion
(Percent) b
Viral entry
(Percent) c
CD4 Ig
binding d
1084i
WT 1.00 100.00 100.00 n.d.
303Gi 0.50 5.40 * 3.19 * n.d.
322G- 0.56 27.57 * 3.93 * n.d.
M307A 0.77 88.68 16.91 * n.d.
M307E 0.68 93.94 3.64 * n.d.
M307L 1.15 89.81 * 573.49 * n.d.
I309A 0.79 55.72 * 2.53 * n.d.
I309E 0.55 4.97 * 0.66 * n.d.
I309L 1.13 76.15 * 35.93 * n.d.
F317A 0.86 58.57 * 2.70 * n.d.
F317E 0.65 35.26 * 3.37 * n.d.
F317L 1.13 80.68 * 65.28 * n.d.
ZM249M-B10
WT 1.00 100.00 100.00 1.00
303Gi 0.15 2.47 * 0.56 * 0.98
I307A 0.08 12.17 * 0.58 * 0.97
I307E 0.05 6.15 * 0.61 * n.d.
I307L 0.29 67.91 * 72.06 * n.d.
I309A 0.08 2.45 * 0.66 * 1.03
I309E 0.13 2.78 * 0.50 * n.d.
I309L 0.82 54.70 * 36.31 * n.d.
F317A 0.13 5.27 * 0.56 * 0.90
F317E 0.21 2.68 * 0.52 * n.d.
F317L 0.40 38.76 * 105.17 n.d.
SIVmac239
WT 1.00 100.00 100.00 1.00
303Gi 0.14 11.55 * 0.96 * 0.71
V307A 0.19 49.86 * 1.07 * 1.03
I309A 0.48 99.36 5.01 * 0.92
F317A 0.14 33.45 * 1.18 * 0.89
SIVagmTan1
WT 1.00 100.0 n.d n.d.
303Gi 0.45 30.20 * n.d n.d.
V307A 0.41 41.31 * n.d n.d.
I309A 0.46 46.92 * n.d n.d.
F317A 0.53 51.46 * n.d n.d.
HIV-2 ST
WT 1.00 100.0 n.d 1.00
303Gi 0.43 5.96 * n.d 0.65
I307A 0.33 8.29 * n.d 1.03
L309A 0.34 5.06 * n.d 0.67
F317A 0.37 6.30 * n.d 0.63
Table 1. a. The association index is a measure of the envelope stability as in-
dicated by the amount of radiolabeled WT or mutant gp120 shed into the
media. The association index was calculated as follows: ([mutant gp120]cell x
[wild-type gp120]supernatant)/([mutant gp120]supernatant x [wild-type gp120]cell).
The association index of the mutants is shown as a proportion of the WT env,
which is set to 1.0.
b. Cell-cell fusion was assessed by coincubation of 293 T cells expressing WT or
mutant env and Tat with TZMbl target cells in a ratio of 1:1, and luciferase was
measured. Cell-cell fusion values of the respective WT strains were set to 100%,
and mutants were expressed as a percentage of the WT value. * , indicates
significant difference compared to WT Env, as determined by student's T-test
(p < 0.05).
c. Viral entry was measured as by infecting CD4+CCR5+ cells with replica-
tion deficient viruses expressing WT or mutant envs. Luciferase was measured
as an indication of viral entry. Viral entry values of WT viruses were set to
100% and the values for the mutants are shown as a percentage of the WT
value. * , indicates significant difference compared to WT, as determined by
student's T-test (p < 0.05).
d. CD4-Ig binding of WT gp120 was established by comparing the quantity of
cell supernatant bound by CD4-Ig to the total gp120 immunoprecipitated by
infected host serum; values for the mutants were compared to this value. n.d.
not determined.
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Fig. 5. Characterization of V3 hydrophobic-patch and glycine-insertion
mutants of the HIV-2 ST strain. (A). Immunoprecipitated cell lysates (CL) and
supernatants (Sup) of WT HIV-2 ST Env and glycine-insertion (303Gi) and
hydrophobic patch mutants. The association index value was calculated as
previously reported (Finzi et al., 2010). (B). Cell-cell fusion assay. Un, un-
transfected effector cells. (C). CD4-binding assay. CD4-Ig was used to pre-
cipitate the indicated gp120 glycoproteins in transfected cell supernatants. Un,
untransfected cells. The binding ratio of the mutants was compared to the
binding ratio of the WT Env, as described in Materials and Methods. The results
in this figure are representative of those obtained in three separate binding
experiments.
Significance was determined by the student's T-test [*p < 0.05, * *p < 0.01,
* ** *p < 0.0001]; n.s., not significant.
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phenotypes similar to those of the wild-type virus (Herschhorn et al.,
2016; Madani et al., 2017). Conformational differences between the
high-resolution Env trimer structures and that of the pre-triggered Env
on virions have been suggested (Alsahafi et al., 2015; Castillo-
Menendez et al., 2018; Pancera et al., 2017). Therefore, in the pre-
triggered virion Env trimer, the residues in the V3 hydrophobic patch
may contribute to Env trimer stability through interactions not evident
in current high-resolution structures. Additional structural information
on the conformations sampled by the pre-triggered HIV-1 Env trimer
may shed light on the mechanism whereby the V3 loop contributes to
trimer stability.
CD4 binding repositions the V3 loop from a relatively buried loca-
tion to an extended structure that can interact with the CCR5 or CXCR4
chemokine receptors (Fig. 8). Coreceptor-binding sites in the V3 tip and
base are made available for interaction with the chemokine receptor
ECL2 and N-terminus, respectively. In this CD4-bound conformation,
the distance (Z) between the V3 base and tip may be constrained by the
distance between the N-terminal and ECL2 contacts on the chemokine
receptor. In a previous report (Xiang et al., 2010), we found that the
decreased syncytium-forming ability of some glycine-insertion V3 mu-
tants could be partially compensated by a CCR5 mutant with an N-
terminus extended by two glycine residues. The hydrophobic patch
contributes to the interaction of the V3 tip with the chemokine receptor
ECL2. Changing the hydrophobic patch residues in HIV-1 gp120 to
alanine allowed partial CCR5 binding, but substitution of polar (serine)
or charged (glutamic acid) residues abolished detectable CCR5 inter-
action. These results imply that hydrophobic contacts may be required
for the efficient interaction of the V3 tip and ECL2 of the chemokine
receptor. Differences in the amount of shed gp120 and in the utilization
of monkey versus human receptors complicate quantitative compar-
isons of the relative contribution of the V3 hydrophobic patch to HIV-1/
SIV and HIV-1 coreceptor interaction. However, from previous data
derived with HIV-1 (Xiang et al., 2010), we expect that glycine inser-
tions and reduction of hydrophobicity in the hydrophobic patch of the
HIV-2/SIV gp120 V3 region will significantly decrease CCR5 binding.
Future studies should provide additional insights into the dual roles
of the primate immunodeficiency virus V3 hydrophobic patch in
maintenance of Env trimer stability and in coreceptor binding.
4. Methods and materials
4.1. Cell lines
293 T cells were used for Env expression experiments, as effector
Fig. 6. Characterization of V3 hydrophobic-
patch and glycine-insertion mutants of SIV
strains. (A). Immunoprecipitated cell lysates
(CL) and supernatants (Sup) of glycine-insertion
(303Gi) and hydrophobic-patch mutants of
SIVmac239. The association index value was
calculated as previously reported (Finzi et al.,
2010). (B). Cell-cell fusion assay of SIVmac239
Env variants. (C). Viral entry of SIVmac239 Env
variants. (E). Immunoprecipitated cell lysates
(CL) and supernatants (Sup) of glycine-insertion
and hydrophobic-patch mutants of SI-
VagmTan1. (F). Cell-cell fusion assay of SI-
VagmTan1 Env variants. Un, untransfected ef-
fector cells. Significance was determined by the
student's T-test [* ** *p < 0.0001]; n.s., not
significant.
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cells for the cell-cell fusion assay and to produce the single-round virus
for entry assays. 293 T cells were grown in Dulbecco's modified Eagle
Medium (DMEM) containing 10% fetal bovine serum, 8mM L-gluta-
mine and 100 μg/mL penicillin/streptomycin solution (complete
DMEM). TZM-bl cells were grown in complete DMEM as described
above, and were used as the target cells for the cell-cell fusion and virus
entry assays. Cf2Th-CD4/CCR5 and Cf2Th-CCR5 were grown in com-
plete DMEM; the Cf2Th-CD4/CCR5 cell medium was supplemented
with 500 μg/mL G418 and 150 μg/mL Hygromycin B, and the Cf2Th-
CCR5 cell medium was supplemented with 500 μg/mL G418.
4.2. Plasmids
Plasmids for envelope expression were generated by subcloning.
The ZM249MB_10 (referred to as ZM249), HIV-2 ST and SIVagmTan1
envelope expression plasmids were generated by PCR amplification of
the env genes from existing envelope expression plasmids or proviral
constructs and ligation into pcDNA3.1+ for expression in mammalian
cells. The envelope gene of ZM249 was amplified from the plasmid
pZM249 (Parrish et al., 2013; Salazar-Gonzalez et al., 2009) by PCR
using primers that added a 5’ HindIII site and 3’ EcoRI site. The HIV-2
ST envelope gene was amplified from the pHIV2/ST molecular clone
(Kong et al., 1988; Kumar et al., 1990), adding a 5’ AflII site and a 3’
BamHI site, and subcloned into pcDNA3.1+. The SIVagmTan1 en-
velope gene was amplified from the pSIVagmTan-1 molecular clone
(Soares et al., 1997), adding a KpnI site to the 5’ end of the gene and an
EcoRI site to the 3’ end of the gene, followed by subcloning into
pcDNA3.1+ . 1084i (Zhang et al., 2006) was subcloned into the
pSVIIIenv plasmid expressing the HIV-1 HXBc2 Rev and Env proteins,
using the KpnI site, which is conserved, and the BamHI site. A BamHI
site corresponding to the existing BamHI site in HXBc2 was introduced
into the 1084i sequence by site-directed mutagenesis. Following sub-
cloning, all Env expressor constructs were sequenced to verify the in-
tegrity of the env gene. Mutations to alter the V3 loop hydrophobic
patch were also made directly to ZM249 for pseudotyped virus pro-
duction (Marcon et al., 1997; Xiang et al., 2002). All ligations were
carried out using T4 DNA Ligase from New England Biolabs.
4.3. Site-directed mutagenesis
The V3 loop hydrophobic patch substitution and insertion mutants
in HIV-1 subtype C strains (ZM249 and 1084i), HIV-2 ST, SIVagmTan1
and SIVmac239 were made by site-directed mutagenesis, using PfuUltra
(Agilent) and the QuikChange XL protocol. The primers for mutagenesis
Fig. 7. Interaction of the gp120 V3 loop hydrophobic patch and V2 loop in the sgp140 SOSIP.664 Env trimer. (A). HIV-1 sgp140 SOSIP.664 Env trimer
structure in the unbound state (PDB: 4ZMJ). V3, magenta; V2, cyan. (B). Ribbon structure of V2 and V3 loops showing a key-in-hole interaction, with specific focus
on the V3 hydrophobic patch residues at positions I307, I309 and F317 and with the hydrophobic cavity residues (i.e. F159, M161 and V172) of V2 loop. (C). V2
surface model showing the hydrophobic cavity (circled in cyan) interacting with the V3 loop hydrophobic patch. Gray, hydrophobic; blue, hydrophilic.
Fig. 8. Conformational changes in the gp120 V3 loop. Model of super-
imposed gp120 structures without CD4 (gray) and CD4-bound (cyan) states,
showing the shift in the position of the V3 loop. The V3 hydrophobic patch
residues 307, 309 and 317 are shown in magenta. The V3 base residue N302
that interacts with the sulfated CCR5 N-terminus is also indicated in red. Part of
the V2 loop in the unbound state is omitted for better visualization of the
bridging sheet and V3 loop. The X-ray structures used for the superimposed
structures are PDB: 4ZMJ (Kwon et al., 2015) for the unbound sgp140
SOSIP.664 state and PDB: 2QAD (Huang et al., 2007) for the CD4-bound state.
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were synthesized by Integrated DNA Technologies (IDT).
4.4. Cell-cell fusion assay
On Day 0, 3.5× 105 293 T cells were plated in a 6-well plate. The
following day, the cells were transfected with 2 μg of WT or mutant Env
expression constructs and 1 μg Tat-expressing plasmid using poly-
ethylynamine (PEI). Twenty-four hours following transfection, the
medium was changed on the transfected cells, and TZM-bl cells were
distributed in a black 96-well plate at a density of 1.0× 104 per well.
On Day 3, the transfected 293 T cells were detached from the plate
using gentle pipetting and counted in a hemocytometer. Approximately
1.0×104 of the transfected effector cells were distributed into the
wells containing the previously plated TZM-bl cells and the cells were
co-incubated for 16 h. Following co-incubation, the cells were washed
once with PBS, lysed using 1× Passive Lysis Buffer (Promega) and
frozen at −80 °C. After thawing, he plates were read for luciferase
activity using the beetle luciferin substrate (Promega) and a Veritas
Luminometer. Values for the cell-cell fusion activities of WT Envs were
set to 100% and mutant values are expressed as a percentage of the WT
value.
4.5. Assay measuring Env processing and subunit association
293 T cells were set at a density of 3.5× 105 in a 6-well plate. The
following day, the cells were transfected with WT or mutant Env ex-
pression construct. One day post transfection, the cells were metaboli-
cally labeled overnight using the EasyTag EXPRESS35S Protein Labeling
Mix [35S] (PerkinElmer). Following labeling, the supernatants were
harvested and clarified of cell debris by gentle centrifugation.
Separately, the cells were lysed using a mild NP-40-based lysis buffer.
The cell lysates were precleared using appropriate uninfected serum for
8 h as previously described (Bohl et al., 2013). Following the pre-
clearing, the cell lysates and supernatant fractions were separately
subjected to immunoprecipitation with serum from the corresponding
virus-infected host, using Protein-A Sepharose beads (GE Health Sci-
ences). The samples were run on SDS-PAGE and the gels were dried and
exposed to a phosphor screen. Phosphor screens were developed using a
Personal Molecular Imager (Biorad) and analyzed using QuantityOne
software (Biorad). Values for the supernatant and cell lysate band were
determined and the association index was calculated as previously de-
scribed (Finzi et al., 2010).
4.6. Generation of pseudotyped viruses
293 T cells were plated at a density of 3.5× 105 cells per well in a 6-
well plate. Twenty-four hours later, the cells were transfected with a
WT or mutant Env expression plasmid and an env-deficient viral
backbone (pSG3deltaEnv from the NIH AIDS Reagent Program (Wei
et al., 2002, 2003) in the case of ZM249 and SIVmac239 constructs, or
pHIV-1Luc and CMVPack for 1084i constructs) using PEI. One day
following transfection, additional medium was added to the wells.
Three days post transfection, the supernatants were harvested, briefly
spun down to remove cell debris and stored at −80 °C. The pseudo-
virus-containing supernatants were then quantified using the reverse
transcriptase assay.
4.7. Reverse transcriptase assay
To quantify the amount of pseudovirus in a sample, the reverse
transcriptase assay was performed. In duplicate, 500 μL of pseudovirus-
containing supernatant was spun at 14,000xg for 2 h at 4 °C. Following
the spin, the supernatant was removed and the viral pellet was re-
suspended in a Triton X-100-based suspension buffer and vortexed,
followed by a rapid freeze-thaw cycle a total of three times to lyse the
virus. Fifty microliters of reaction mix (Oligo-dT Poly-A and 3H-dTTP
(PerkinElmer)) was added, and the samples were incubated at 37 °C for
1 h in a heating block. Following incubation, the samples were pipetted
onto cut squares of DEAE Filtermat paper (PerkinElmer), followed by
three ten-minute washes in 2× SSC buffer, and one ten-second wash in
100% ethanol. The filters were dried at room temp and then analyzed
using a scintillation counter to quantify the incorporation of 3H-dTTP
into cDNA. The average CPM values from each duplicate were then
used to normalize the amount of virus-containing supernatant that was
used in subsequent single-round viral entry assays.
4.8. Single-round viral infection assay
Cf2Th-CD4/CCR5 or TZM-bl cells, which express both human CD4
and CCR5, were plated at a density of 8.0× 103 per well (Cf2Th-CD4/
CCR5 cells were used in the case of 1084i Env-expressing pseudo-
viruses, and TZM-bl cells were used in the case of ZM249, ADA, JR-FL
and SIVmac239 Env-expressing viruses). The following day, a volume
of virus, normalized based on the level of RT activity in the supernatant,
was added to each well in a final volume of 100 μL, and diluted in
complete DMEM. One day after infection, the viral supernatants were
removed, the cells were gently washed one time with PBS and fresh
complete media was added to each well. On day 3 post infection, the
supernatants were removed, the cells were washed once with PBS, and
the cells were lysed in 1× Passive Lysis Buffer and frozen at −80 °C.
The plates were then thawed and luciferase activity was measured using
the Veritas Luminometer and beetle luciferin substrate (Promega).
4.9. CD4 binding assay
35S-labeled supernatants from cells expressing WT or mutant Envs
were assessed for CD4 binding by performing an immunoprecipitation
assay using human CD4-Ig. Input quantities were determined by per-
forming an immunoprecipitation using the same volume of supernatant
and serum from an appropriate virus-infected host. To measure the CD4
binding of HIV-2 ST variants, three times the volume of supernatant
was used for comparison with the WT Env, because of a reduced level of
binding to CD4-Ig compared to HIV-1 species. Following im-
munoprecipitation with CD4-Ig, the bands were quantified using
Quantity One software (Biorad) and the volumes were compared to the
volumes of the input gel. The ratio of WT CD4-Ig: serum im-
munoprecipitation was adjusted to 1, and the ratios for the mutants
were compared to the WT values.
4.10. Statistical analysis
For all statistical analyses of cell-cell fusion and single-round viral
infection assays, experimental groups were compared using the
Student's T-test. Each experiment was performed three separate times,
with quadruplicate values. Each mutant value was converted to a per-
centage of the WT value, which was set at 100%. Significant differences
were determined using a p-value of ≤0.05. All statistical analysis was
performed using GraphPad Prism 6 software.
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